1. Home
  2. LGND vs MAN Comparison

LGND vs MAN Comparison

Compare LGND & MAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • MAN
  • Stock Information
  • Founded
  • LGND 1987
  • MAN 1948
  • Country
  • LGND United States
  • MAN United States
  • Employees
  • LGND N/A
  • MAN N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • MAN Professional Services
  • Sector
  • LGND Health Care
  • MAN Consumer Discretionary
  • Exchange
  • LGND Nasdaq
  • MAN Nasdaq
  • Market Cap
  • LGND 2.0B
  • MAN 2.0B
  • IPO Year
  • LGND 1992
  • MAN 1988
  • Fundamental
  • Price
  • LGND $122.40
  • MAN $44.77
  • Analyst Decision
  • LGND Strong Buy
  • MAN Hold
  • Analyst Count
  • LGND 8
  • MAN 5
  • Target Price
  • LGND $144.71
  • MAN $50.60
  • AVG Volume (30 Days)
  • LGND 139.7K
  • MAN 919.5K
  • Earning Date
  • LGND 08-05-2025
  • MAN 07-17-2025
  • Dividend Yield
  • LGND N/A
  • MAN 5.05%
  • EPS Growth
  • LGND N/A
  • MAN 129.57
  • EPS
  • LGND N/A
  • MAN 2.33
  • Revenue
  • LGND $181,488,000.00
  • MAN $17,540,900,000.00
  • Revenue This Year
  • LGND $18.41
  • MAN N/A
  • Revenue Next Year
  • LGND $18.87
  • MAN $2.56
  • P/E Ratio
  • LGND N/A
  • MAN $19.22
  • Revenue Growth
  • LGND 53.40
  • MAN N/A
  • 52 Week Low
  • LGND $81.74
  • MAN $37.99
  • 52 Week High
  • LGND $129.90
  • MAN $78.22
  • Technical
  • Relative Strength Index (RSI)
  • LGND 70.36
  • MAN 61.79
  • Support Level
  • LGND $111.72
  • MAN $42.94
  • Resistance Level
  • LGND $115.53
  • MAN $45.33
  • Average True Range (ATR)
  • LGND 3.46
  • MAN 1.42
  • MACD
  • LGND 0.18
  • MAN 0.64
  • Stochastic Oscillator
  • LGND 85.52
  • MAN 94.69

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About MAN ManpowerGroup

ManpowerGroup Inc. is engaged in providing workforce solutions and services. The company provides services that include Recruitment and Assessment, Upskilling, Reskilling, Training and Development, Career Management, Outsourcing, and Workforce Consulting. The reportable segments of the company are Staffing and Interim, Outcome-Based Solutions and Consulting, Permanent Recruitment, and Others. The Staffing and Interim segment derives the maximum of the company's revenue. The company derives maximum geographical revenue from the Southern European region.

Share on Social Networks: